Macrogenics Files DEFA14A Proxy Materials
Ticker: MGNX · Form: DEFA14A · Filed: Apr 8, 2026 · CIK: 0001125345
Sentiment: neutral
Topics: proxy-filing, corporate-governance
Related Tickers: MGNX
TL;DR
MGNX filed proxy docs, likely for shareholder votes. Stay tuned.
AI Summary
Macrogenics Inc. filed a Definitive Additional Materials (DEFA14A) on April 8, 2026, related to proxy solicitations. The filing includes notice pages and a complete submission text file, indicating ongoing corporate communications and shareholder engagement. The company's mailing and business address is 9704 Medical Center Drive, Rockville, MD 20850.
Why It Matters
This filing is a routine but important part of corporate governance, informing shareholders about matters requiring their vote or attention, which can impact company direction.
Risk Assessment
Risk Level: low — This is a standard proxy filing, not indicating immediate financial distress or significant strategic shifts.
Key Players & Entities
- MACROGENICS INC (company) — Filer
- 0001125345 (company) — CIK Number
- 2026-04-08 (date) — Filing Date
- 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 (address) — Mailing and Business Address
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for Additional Definitive Materials and Rule 14(a)(12) material, typically related to proxy solicitations where a company provides supplemental information to shareholders.
When was this specific DEFA14A filing made by Macrogenics Inc.?
This DEFA14A filing was made on April 8, 2026.
What is Macrogenics Inc.'s CIK number?
Macrogenics Inc.'s CIK number is 0001125345.
Where is Macrogenics Inc. located?
Macrogenics Inc.'s mailing and business address is 9704 Medical Center Drive, Rockville, MD 20850.
What type of documents are included in this filing?
This filing includes a DEFA14A document, notice pages (graphic files), and a complete submission text file.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 8, 2026 regarding MACROGENICS INC (MGNX).